NewsBenzinga아클라리스, 이끼플라누스 환자 대상 모자티닙 2b상 임상시험 개시···기전상 완전한 최초 경구 치료제로서 가능성 있는 패스트트랙 지정 이중 ITK/JAK3 억제제 아클라리스, 이끼플라누스 환자 대상 모자티닙 2b상 임상시험 개시···기전상 완전한 최초 경구 치료제로서 가능성 있는 패스트트랙 지정 이중 ITK/JAK3 억제제 Benzinga 2026.11.16 08:35 (GMT+0) Open on Benzinga Other news New Address Withdraws 1.344 Billion PUMP From Coinbase, Worth About $3.87 Million Key Overnight and Morning News (November 16–17) Crypto Sectors Trade Mixed as DeFi Rises 1.67% While RWA and GameFi Each Drop Over 2% AI Lab Noeri, Founded by Stanford Professors, Raises $110M With Nvidia Among Investors Baidu Q3 Earnings: Total Revenue 30.8 Billion Yuan, AI Business Revenue Share Above Half for Third Straight Quarter Bitcoin, XRP, Dogecoin Slide, Ethereum Steady as ‘Extreme Fear’ Persists: Analyst Says ‘Selling Hasn’t Stopped Yet’ as Whales Offload BTC
Baidu Q3 Earnings: Total Revenue 30.8 Billion Yuan, AI Business Revenue Share Above Half for Third Straight Quarter
Bitcoin, XRP, Dogecoin Slide, Ethereum Steady as ‘Extreme Fear’ Persists: Analyst Says ‘Selling Hasn’t Stopped Yet’ as Whales Offload BTC